SSGJ-706

SSGJ-706 · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SSGJ-706, covering 2024-08-01 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients [Phase 2]

See pricing